TA126 Rheumatoid arthritis (refractory) - rituximab: full guidance
The published full technology appraisal on Rheumatoid arthritis (refractory) - rituximab including recommendations and methods used.
|
TA126 Rheumatoid arthritis (refractory) - rituximab: full guidance
22 August 2007 (177.03 Kb 51 sec) |
